title: What can we learn from the FACIT trial: a randomized, double blind, controlled trial.
authors.affiliation: J. Durga, Cognitive Sciences Group, Nutrition and Health Department, Nestle Research Center. Jane.Durga@rdls.nestle.comwur.nl
authors.forename: J
authors.initials: J
authors.lastname: Durga
authors.forename: M P J
authors.initials: MP
authors.lastname: Van Boxtel
authors.forename: E G
authors.initials: EG
authors.lastname: Schouten
authors.forename: F J
authors.initials: FJ
authors.lastname: Kok
authors.forename: J
authors.initials: J
authors.lastname: Jolles
authors.forename: M B
authors.initials: MB
authors.lastname: Katan
authors.forename: P
authors.initials: P
authors.lastname: Verhoef
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003071:Cognition / Q000187:drug effects* / Q000502:physiology; D004311:Double-Blind Method; D005260:Female; D005492:Folic Acid / Q000097:blood / Q000494:pharmacology*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects* / Q000502:physiology; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011581:Psychological Tests; D011594:Psychometrics; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000097:blood / Q000494:pharmacology*
chemical_list: D006710:Homocysteine; D014803:Vitamin B Complex; D005492:Folic Acid